Position in AMGN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$210,047,343
+$10,576,893 QoQ
Shares Held
580,049
+2.3% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#86
of 3,131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 58%
Shared 0%
None 42%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $4,134,092,265 across 9 Drug Manufacturers - General names. AMGN ranks #8 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
758,740 | $910,055,594 | |
| 2 | ABBV |
AbbVie Inc.
|
3,565,119 | $897,126,545 | |
| 3 | JNJ |
Johnson & Johnson
|
1,966,109 | $499,332,702 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,459,893 | $437,122,881 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
7,244,630 | $417,435,580 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,373,993 | $305,058,100 | |
| 7 | PFE |
Pfizer Inc
|
11,918,197 | $286,990,183 | |
| 8 | AMGN |
Amgen Inc
This page
|
580,049 | $210,047,343 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $210,047,343 | 580,049 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $199,470,450 | 566,919 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $157,584,381 | 481,453 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $123,481,971 | 437,569 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $124,011,679 | 444,152 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $144,218,052 | 462,905 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $109,254,553 | 419,178 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $146,800,487 | 455,605 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $155,999,411 | 499,278 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $284,418,943 | 1,000,348 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $311,464,539 | 1,081,399 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $269,231,405 | 1,001,754 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $237,464,599 | 1,069,564 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $290,563,676 | 1,201,918 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $302,268,961 | 1,150,887 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $270,853,037 | 1,201,655 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $158,440,852 | 651,216 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $144,383,951 | 597,072 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $136,707,969 | 607,672 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $140,647,773 | 661,405 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $166,124,400 | 681,536 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $168,746,176 | 678,213 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $157,382,769 | 684,511 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $171,976,093 | 676,645 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $175,617,110 | 744,582 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $91,217,349 | 449,945 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||